Eurizon Capital SGR S.p.A. increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,159,404 shares of the company’s stock after acquiring an additional 9,323 shares during the period. Eurizon Capital SGR S.p.A. owned 0.05% of Procter & Gamble worth $169,052,000 as of its most recent filing with the SEC.
Other institutional investors have also made changes to their positions in the company. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Procter & Gamble during the second quarter valued at approximately $26,000. Montgomery Financial Services LLC bought a new position in shares of Procter & Gamble in the second quarter valued at approximately $28,000. Paladin Partners LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $29,000. Evergreen Advisors LLC acquired a new stake in shares of Procter & Gamble in the first quarter worth $37,000. Finally, Toews Corp ADV bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $37,000. 65.77% of the stock is owned by institutional investors.
Insider Activity
In other news, CFO Andre Schulten sold 33,624 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $165.00, for a total transaction of $5,547,960.00. Following the transaction, the chief financial officer owned 65,618 shares in the company, valued at approximately $10,826,970. The trade was a 33.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Sundar G. Raman sold 38,253 shares of the business’s stock in a transaction dated Friday, October 30th. The stock was sold at an average price of $165.00, for a total transaction of $6,311,745.00. Following the transaction, the chief executive officer owned 47,745 shares in the company, valued at approximately $7,877,925. The trade was a 44.48% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 200,006 shares of company stock worth $32,715,058. Corporate insiders own 0.23% of the company’s stock.
Procter & Gamble Stock Performance
Shares of NYSE PG opened at $168.02 on Friday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $170.52. The company has a market cap of $389.43 billion, a P/E ratio of 25.30, a P/E/G ratio of 4.12 and a beta of 0.36. The business’s 50 day moving average is $153.80 and its two-hundred day moving average is $149.82. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.11. The company had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. Procter & Gamble’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.99 earnings per share. On average, equities analysts expect that Procter & Gamble Company will post 6.99 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is presently 65.51%.
Wall Street Analysts Forecast Growth
PG has been the topic of a number of research analyst reports. HSBC lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their target price for the company from $182.00 to $149.00 in a research note on Thursday, July 30th. Barclays lifted their target price on shares of Procter & Gamble from $152.00 to $165.00 and gave the stock an “equal weight” rating in a report on Monday, October 26th. Evercore raised shares of Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 target price for the company in a research report on Tuesday, October 6th. Piper Sandler upped their price target on shares of Procter & Gamble from $145.00 to $167.00 and gave the company a “neutral” rating in a report on Monday, October 26th. Finally, Deutsche Bank reaffirmed a “buy” rating on shares of Procter & Gamble in a research report on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $170.57.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble News Summary
Investors following PG have been watching these news items:
- Positive Sentiment: Commentary highlights P&G’s essential household brands, strong cash generation and a 70-year streak of dividend increases; one article cited a recent yield of about 2.6%. These qualities may appeal to income-focused investors. Article: Procter & Gamble Has Raised Its Dividend for 70 Straight Years
- Neutral Sentiment: A valuation analysis questions whether P&G’s share price is supported by future cash flows, noting its 29.7% five-year return. The article raises a valuation question rather than offering a clear near-term catalyst. Article: Is Procter & Gamble Worth More Than Its Price Today?
- Negative Sentiment: CEO El Hak Hesham Abd sold 2,250 shares at an average of $168.47, reducing his direct holding by 20.06% to 8,968 shares. The transaction could raise concerns, though he retains a stake and a sale alone does not establish a change in the company’s outlook. SEC Form 4 filing
Procter & Gamble Company Profile
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
